Posted on 8/8/17
Sean Cavanaugh Joins PatientPing as Advisor
PatientPing, a health technology company that connects providers to seamlessly coordinate patient care, announced today
Posted on 8/8/17
Concert Pharmaceuticals Reports Second Quarter 2017 Financial Results
LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the second quarter of 2017.“We are very pleased that we have closed the . . .
Posted on 8/8/17
Voyager Therapeutics Reports Second Quarter 2017 Financial Results and Corporate Highlights
CAMBRIDGE, Mass., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe neurological diseases, today reported . . .
Posted on 8/8/17
Bristol-Myers - Adding To The Pipeline With IFM
Bristol-Myers Squibb (BMY) announces a bolt-on deal in order to revive its business. The purchase of IFM adds to the oncology pipeline of the company and . . .
Posted on 8/8/17
Why Flexion Therapeutics Shares Shot 12.8% Higher in July
What happenedAfter the company hosted an investor's day on July 10, shares in Flexion Therapeutics(NASDAQ:FLXN) jumped 12.8% last month, according to S&P Global Market Intelligence.So whatFlexion . . .
Posted on 8/8/17
Buyout Bid Overshadows NxStage Medical's Losses
Dialysis patients know how inconvenient it can be to make time for their treatments, and NxStage Medical (NASDAQ:NXTM) has sought to make dialysis much less of . . .
Posted on 8/8/17
bluebird bio Pauses During 2017 Data Blitz
Clinical-stage gene therapy specialist bluebird bio (NASDAQ:BLUE) reported second-quarter earnings last week, which mostly just served as a reminder of its pipeline progress because revenue and . . .
Posted on 8/8/17
Idera Pharmaceuticals Provides Corporate Update
CAMBRIDGE, Mass. and EXTON, Pa., Aug. 07, 2017 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization . . .
Posted on 8/7/17
Wake Forest Baptist Medical Center Joins the TriNetX Global Health Research Network
TriNetX is pleased to announce the addition of Wake Forest Baptist Medical Center to the TriNetX health research network. Wake Forest Baptist, a nationally recognized academic . . .
Posted on 8/7/17
Charles River Laboratories Acquires Brains On-Line
Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has acquired Brains On-Line, a leading contract research organization
Posted on 8/7/17
Fresenius Medical Care To Acquire NxStage Medical
Fresenius Medical Care, the world’s largest provider of dialysis products and services, has signed an agreement to acquire NxStage Medical, Inc.,
Posted on 8/7/17
NxStage Reports Second Quarter Financial Results
NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that its Board of Directors has unanimously approved a . . .
Posted on 8/7/17
Bristol-Myers Squibb: A Combined Value And Growth Story
BackgroundBristol-Myers Squibb (NYSE:BMY) was formed from a merger of two old-line pharma companies more than a quarter century ago. At the time, it was a powerhouse. . . .
Posted on 8/7/17
Vertex Pharmaceuticals vs. Regeneron Pharmaceuticals: Which Company Reported Better Earnings
Vertex Pharmaceuticals (NASDAQ:VRTX) and Regeneron Pharmaceuticals(NASDAQ:REGN) are two big-cap biotech stocks, and each recently reported second-quarter financial results that were better than analysts were expecting. The . . .
Posted on 8/7/17
Berkshire Hathaway: Insurance Losses Drag Down Second-Quarter Operating Earnings
Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) reported that operating earnings, a figure which excludes volatile investment gains and derivative fluctuations, declined 11% to $4.1 billion in the second . . .
Posted on 8/7/17
Why Vertex Pharmaceuticals Skyrocketed 17.8% in July
What happenedAfter reporting results from mid-stage trials showing its multi-drug combination therapies improved lung function in cystic fibrosis patients, Vertex Pharmaceuticals(NASDAQ:VRTX) shares surged 17.8% higher in . . .
Posted on 8/6/17
Boston Plastic Surgery Practice Adds Surgeon Jeffrey H. Lee
Boston Plastic Surgery has announced that plastic surgeon Dr. Jeffrey H. Lee has joined the practice full-time.Fouad Samaha, MD, FACS, board certified plastic surgeon and medical . . .
Posted on 8/6/17
Akebia Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), . . .
Posted on 8/4/17
Radius Health, Inc. 2017 Q2 - Results - Earnings Call Slides
The following slide deck was published by Radius Health, Inc. in conjunction with their 2017 Q2 earnings call. 125READ FULL ARTICLE HERE
Posted on 8/4/17
Cancer Care Specialists of Illinois Partners with New Century Health
New Century Health (NCH) today announced a multi-year collaboration with one of the largest community based multi-specialty oncology practices in Illinois. Cancer Care Specialists of Illinois . . .
Posted on 8/4/17
RXi Pharmaceuticals Granted 180-Day Extension by Nasdaq Stock Market
RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical needs, today announced that the Nasdaq Stock Market granted . . .
Posted on 8/4/17
NeuroMetrix Announces DPNCheck Distribution Agreement with Fukuda Denshi in Japan
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) today reported an agreement with Fukuda Denshi for DPNCheck® distribution in Japan. DPNCheck is NeuroMetrix’ rapid, accurate, and quantitative point-of-care . . .
Posted on 8/3/17
Proteon Therapeutics Announces Closing of $22 Million Convertible Preferred Stock Financing
WALTHAM, Mass., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with . . .
Posted on 8/3/17
Agilis Biotherapeutics and Gene Therapy Research Institution Enter into Strategic Partnership
CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Agilis Biotherapeutics, Inc. (Agilis), a biotechnology company advancing innovative DNA therapeutics for rare genetic diseases that affect the central nervous system (CNS), . . .
Posted on 8/8/17
BioAxone BioSciences Receives Notice of Award
CAMBRIDGE, Mass.--(BUSINESS WIRE)--BioAxone BioSciences, Inc., an emerging, clinical-stage biotechnology company focused on developing innovative drugs to restore neurological function, today announced that the National Institutes of . . .
Boston
